VISTAGEN THERAPEUTICS, INC.

Profile

Company Names

VISTAGEN THERAPEUTICS, INC.

Addresses

343 ALLERTON AVENUE, SOUTH SAN FRANCISCO, CA 94080

384 OYSTER POINT BLVD, NO. 8, SOUTH SAN FRANCISCO, CA 94080

Phone Numbers

650-577-3600
650-244-9990

 

Entity Type:

CORPORATION

Industry:

PHARMACEUTICALS, BIOTECHNOLOGY

Year Incorporated:

> 5 years ago

State Incorporated:

NEVADA

Total Amount Raised:

$13,216,781.00

Number of Funding Rounds:

8
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
8
2023-02-02 
$0.00 
$2,798,415.00 
$2,798,415.00 
Equity 
7
2020-01-24 
$2,750,000.00 
$2,750,000.00 
$0.00 
 
6
2019-10-30 
$650,000.00 
$650,000.00 
$0.00 
Equity 
5
2018-06-28 
$4,778,750.00 
$5,750,000.00 
$971,250.00 
Equity 
4
2017-03-30 
$1,037,750.00 
$1,037,750.00 
$0.00 
Equity 
3
2015-05-26 
$1,930,281.00 
$10,000,000.00 
$8,069,719.00 
Equity 
2
2014-03-14 
$1,570,000.00 
$3,000,000.00 
$1,430,000.00 
Equity, Debt 
1
2012-02-28 
$500,000.00 
$3,000,000.00 
$2,500,000.00 
Debt 
People
First Name
Middle Name
Last Name
Titles
Related Companies
REID 
G. 
ADLER 
EXECUTIVE OFFICER
VISTAGEN THERAPEUTICS, INC.
GREGORY 
A. 
BONFIGLIO 
DIRECTOR
VISTAGEN THERAPEUTICS, INC.   |  IMMUNEBRIDGE INC.
UNDERDOWN 
J. 
BRIAN 
DIRECTOR
VISTAGEN THERAPEUTICS, INC.
ANN 
K. 
CUNNINGHAM 
DIRECTOR
VISTAGEN THERAPEUTICS, INC.
ANN 
M. 
CUNNINGHAM 
DIRECTOR
VISTAGEN THERAPEUTICS, INC.
JOANNE 
 
CURLEY 
DIRECTOR
VISTAGEN THERAPEUTICS, INC.
JERROLD 
D. 
DOTSON 
EXECUTIVE OFFICER
VISTAGEN THERAPEUTICS, INC.
MARGARET 
M. 
FITZPATRICK 
DIRECTOR
VISTAGEN THERAPEUTICS, INC.
JERRY 
B. 
GIN 
DIRECTOR
VISTAGEN THERAPEUTICS, INC.
MARK 
A. 
MCPARTLAND 
EXECUTIVE OFFICER
STELLAR BIOTECHNOLOGIES, INC.   |  VISTAGEN THERAPEUTICS, INC.
A. 
FRANKLIN 
RICE 
EXECUTIVE OFFICER
VISTAGEN THERAPEUTICS, INC.
MARY 
L. 
ROTUNNO 
DIRECTOR
VISTAGEN THERAPEUTICS, INC.
JON 
S. 
SAXE 
DIRECTOR
VISTAGEN THERAPEUTICS, INC.   |  LUMOS PHARMA, INC.   |  EPALEX CORP
SHAWN 
K. 
SINGH 
EXECUTIVE OFFICER, DIRECTOR
ECHO THERAPEUTICS, INC.   |  VISTAGEN THERAPEUTICS, INC.
MARK 
A. 
SMITH 
EXECUTIVE OFFICER
GEOSPATIAL HOLDINGS, INC.   |  BION ENVIRONMENTAL TECHNOLOGIES INC   |  NIOCORP DEVELOPMENTS LTD   |  INFINITE HARVEST, INC.   |  IBC ADVANCED ALLOYS CORP.   |  LARGO RESOURCES LTD.   |  VISTAGEN THERAPEUTICS, INC.
H. 
RALPH 
SNODGRASS 
EXECUTIVE OFFICER, DIRECTOR
VISTAGEN THERAPEUTICS, INC.
BRIAN 
J. 
UNDERDOWN 
DIRECTOR
VISTAGEN THERAPEUTICS, INC.
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
2023-02-21
D
Link
PHARMACEUTICALS 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
Equity 
2023-02-02 
2020-01-31
D
Link
PHARMACEUTICALS 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
 
2020-01-24 
2019-12-12
D
Link
BIOTECHNOLOGY 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
Equity 
2019-10-30 
2018-09-21
D
Link
BIOTECHNOLOGY 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
Equity 
2018-06-28 
2017-08-22
D
Link
BIOTECHNOLOGY 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
Equity 
2017-03-30 
2015-08-06
D
Link
BIOTECHNOLOGY 
PHARMACEUTICAL PREPARATIONS [2834] 
NO REVENUES 
Equity 
2015-05-26 
2014-06-30
D
Link
BIOTECHNOLOGY 
PHARMACEUTICAL PREPARATIONS [2834] 
$1 - $1,000,000 
Equity, Debt 
2014-03-14 
2012-03-07
D
Link
BIOTECHNOLOGY 
PHARMACEUTICAL PREPARATIONS [2834] 
$1,000,001 - $5,000,000 
Debt 
2012-02-28 
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#
NONE
NONE
NOBLE FINANCIAL CAPITAL MARKETS
15768